Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCR4-NOT transcription complex subunit 6-like (CNOT6L) is a ubiquitously expressed poly(A)-specific ribonuclease enzyme and member of the EEP superfamily, serving as a core catalytic subunit of the multimeric CCR4-NOT transcription complex. CNOT6L catalyzes magnesium-dependent deadenylation, acting mainly in the cytoplasm to shorten the poly(A) tails of specific mRNAs, thus regulating their stability and controlling gene expression at the post-transcriptional level. Its activity directly impacts cell proliferation, cell cycle progression, and tumor suppressor functions. Structurally, CNOT6L has a C-terminal nuclease domain and an N-terminal leucine-rich repeat domain, with the former responsible for strict poly(A) RNA specificity. CNOT6L’s mRNA also encodes stable circular RNA (circCNOT6L), linked to certain cancer phenotypes. Human CNOT6L is functionally distinct from its paralog CNOT6 and is essential for efficient cell growth, with unique tissue distribution and biological effects, particularly in cancer biology[1][2][3][4][5].
No known drugs target CNOT6L directly, so mechanism for drug action is not established. If targeted by inhibitors or RNA-based therapeutics, the likely mechanism would be inhibition or knockdown of its mRNA-deadenylase activity, affecting mRNA stability and, subsequently, cellular proliferation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCR4-NOT transcription complex subunit 6-like (CNOT6L).